Skip to main content

Sutter Martin P's Form 4 filing

Abiomed IncABMD · filed Feb 17, 2022

Accession no.
0001179110-22-001397
Filed
Feb 17, 2022
Trade date
Feb 15, 2022
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 9 non-derivative transactions. Open-market sales total $607.3K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Sutter Martin PCIK 0001017832Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Feb 15, 2022Common Stock, $0.01 par valueSSaleDisposed−11$296.18F2−$3,257.98138,379Direct
Feb 15, 2022Common Stock, $0.01 par valueSSaleDisposed−32$298.50F3−$9,552138,347Direct
Feb 15, 2022Common Stock, $0.01 par valueSSaleDisposed−157$301.00F4−$47,257138,190Direct
Feb 15, 2022Common Stock, $0.01 par valueSSaleDisposed−159$301.56F5−$47,948.04138,031Direct
Feb 15, 2022Common Stock, $0.01 par valueSSaleDisposed−312$302.70F6−$94,442.4137,719Direct
Feb 15, 2022Common Stock, $0.01 par valueSSaleDisposed−460$303.65F7−$139,679137,259Direct
Feb 15, 2022Common Stock, $0.01 par valueSSaleDisposed−536$304.52F8−$163,222.72136,723Direct
Feb 15, 2022Common Stock, $0.01 par valueSSaleDisposed−185$305.71F9−$56,556.35136,538Direct
Feb 15, 2022Common Stock, $0.01 par valueSSaleDisposed−148$306.68F10−$45,388.64136,390Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

This price represents the sale price of the transactions on the reported date at $296.18. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.

Referenced by the price of 1 transaction in Table I.

F3

This price represents the sale price of the transactions on the reported date at $298.50. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.

Referenced by the price of 1 transaction in Table I.

F4

This price represents the sale price of the transactions on the reported date at $301.0046. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.

Referenced by the price of 1 transaction in Table I.

F5

This price represents the sale price of the transactions on the reported date at $301.5608. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.

Referenced by the price of 1 transaction in Table I.

F6

This price represents the sale price of the transactions on the reported date at $302.6986. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.

Referenced by the price of 1 transaction in Table I.

F7

This price represents the sale price of the transactions on the reported date at $303.6477. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.

Referenced by the price of 1 transaction in Table I.

F8

This price represents the sale price of the transactions on the reported date at $304.5160. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.

Referenced by the price of 1 transaction in Table I.

F9

This price represents the sale price of the transactions on the reported date at $305.7072. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.

Referenced by the price of 1 transaction in Table I.

F10

This price represents the sale price of the transactions on the reported date at $306.6811. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)